Skip to main content

CAR-T Cell Therapy Specialists

427 verified specialists treating car-t cell therapy from across the United States are listed on this page. Top affiliations among the highest-ranked specialists include Children's Hospital Los Angeles, Intermountain Healthcare, and Dana-Farber Cancer Institute. Drill into a state below to find specialists nearer to you, or compare individual profiles for credentials, focus areas, and clinical depth.

Michael Pulsipher

Michael Pulsipher, M.D.

Professor of Pediatrics

Pediatrics

Los Angeles, CA30+ years
Pediatric Hematology-Oncology
Daniel Deangelo

Daniel Deangelo, M.D.,PH.D.

Chief, Division of Leukemia Institute Physician; Professor of Medicine, Harvard Medical School

Hematology

Boston, MA30+ years
Hematology & Oncology
Edward Stadtmauer

Edward Stadtmauer, MD

Director, Hematologic Malignancies Clinical/Translational Research, Division of Hematology/Oncology; Roseman, Tarte, Harrow, and Shaffer Families' President's Distinguished Professor

Hematology

Philadelphia, PA30+ years
Hematology & OncologyMedical Oncology
Eric Jacobsen

Eric Jacobsen, MD

Associate Professor of Medicine, Harvard Medical School; Clinical Director, Adult Lymphoma Program; Director, Histiocyte Disorders Center

Hematology

Boston, MA20+ years
Hematology & Oncology
Sattva Neelapu

Sattva Neelapu, M.D.

Professor, Department of Lymphoma/Myeloma, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX

Oncology

Houston, TX30+ years
Hematology & OncologyMedical Oncology
Leo Gordon

Leo Gordon, MD

Professor, Feinberg School of Medicine

Hematology

Chicago, IL30+ years
Hematology & Oncology
John Glaspy

John Glaspy, MD

Professor of Medicine

Hematology

Torrance, CA30+ years
Hematology & Oncology
Stephen Schuster

Stephen Schuster, MD

Robert and Margarita Louis-Dreyfus Professor in Chronic Lymphocytic Leukemia and Lymphoma Clinical Care and Research; Director, Lymphoma Translational Research, Abramson Cancer Center; Associate Professor, Medicine

Hematology

Philadelphia, PA30+ years
Hematology & Oncology
Jane Winter

Jane Winter, MD

Professor, Feinberg School of Medicine, Division of Hematology Oncology

Hematology

Lake Forest, IL30+ years
Hematology & Oncology
Ann Lacasce

Ann Lacasce, M.D.

Associate Professor of Medicine, is a lymphoma specialist and is the Director of the Dana-Farber/Mass General Brigham Fellowship in Hematology/Oncology. She serves

Oncology

Milford, MA30+ years
Medical Oncology
Ranjana Advani

Ranjana Advani, MD

Saul Rosenberg Professor of Lymphoma; Physician Leader, Lymphoma Clinical Care Program

Oncology

Stanford, CA30+ years
Medical OncologyHematology & Oncology
Steven Horwitz

Steven Horwitz, MD

Lymphoma Specialist & Cellular Therapist

Oncology

New York, NY30+ years
Hematology & OncologyMedical Oncology
Paolo Caimi

Paolo Caimi, M.D.

Associate Professor of Medicine, Cleveland Clinic Lerner College of Medicine; Associate Director for Cell Therapy, Cleveland Clinic Taussig Cancer Center

Hematology

Cleveland, OH20+ years
Hematology & Oncology
Sunita Nasta

Sunita Nasta, MD

Section Chief, Lymphoma, Hematology-Oncology; Professor of Clinical Medicine (Hematology-Oncology); Chair, Clinical Trials Review Monitoring Committee; Committee Chair, Penn Institutional Review Board

Hematology

Philadelphia, PA30+ years
Hematology & OncologyMedical Oncology
Adil Daud

Adil Daud, MD

Cutaneous (Skin) Medical Oncology

Oncology

San Francisco, CA30+ years
Medical Oncology
Michael Morse

Michael Morse, M.D.

Professor of Medicine, Duke University School of Medicine

Hematology

Durham, NC30+ years
Hematology & Oncology
Loretta Nastoupil

Loretta Nastoupil, M.D.

Associate Professor, Director of the Lymphoma Outcomes Database, and Section Chief of New Drug Development, Department of Lymphoma and Myeloma

Hematology

Durango, CO15+ years
Hematology & OncologyMedical Oncology
Anjali Advani

Anjali Advani, M.D.

Hematology

Cleveland, OH30+ years
Malignant Hematology
Arnold Freedman

Arnold Freedman, MD

Professor of Medicine at Harvard Medical School, a member of Dana-Farber Cancer Institute's Department of Medical Oncology, and an attending physician at Brigh; Professor of Medicine, Harvard Medical School

Oncology

Boston, MA30+ years
Medical Oncology
David Dingli

David Dingli, M.D.

Professor of Medicine, Division of Hematology, Mayo Clinic

Hematology

Rochester, MN30+ years
Hematology & Oncology

CAR-T Cell Therapy specialists by state

Find car-t cell therapy specialists in your state.

Frequently Asked Questions

How is this national list of car-t cell therapy specialists built?
This page includes physicians in Convene Health's public directory whose profile lists CAR-T Cell Therapy as a clinical focus area, ranked by composite score (research output, peer recognition, frequency of care, and outcomes signals). Each profile is sourced from the NPI registry, peer-reviewed publication data, board certification records, and the physician's own bio where available.
What should I look for when choosing a car-t cell therapy specialist?
Start with clinical fit — the right specialist for car-t cell therapy depends on the specific subtype and severity of your condition. Compare credentials, hospital affiliations, years of experience, peer-reviewed publications, and how the profile describes their approach. Many top specialists are concentrated at academic medical centers; if you have flexibility on location, the top of this list is a strong starting set.
Are these car-t cell therapy specialists accepting new patients?
Profile detail on availability and accepted insurance varies. Open a specific provider profile to see what they've published about new-patient access, insurance accepted, and typical wait times. Coverage details can change — confirm directly with the practice before your visit.
What is CAR-T Cell Therapy?
CAR-T Cell Therapy is a clinical focus area covered by the specialists listed here. Each provider profile describes their training, sub-specialties, and the conditions they regularly treat — open a profile for the most authoritative description of how that specific physician approaches car-t cell therapy care.